| Attribute |
Value |
| 52 Week Change |
-0.9813245 |
| Address1 |
1,955 Lake Park Drive |
| Address2 |
Suite 380 |
| All Time High |
3,266.25 |
| All Time Low |
0.271 |
| Ask |
17.5 |
| Ask Size |
15 |
| Average Daily Volume10 Day |
1,548,750 |
| Average Daily Volume3 Month |
771,873 |
| Average Volume |
771,873 |
| Average Volume10Days |
1,548,750 |
| Beta |
3.686 |
| Bid |
0.2785 |
| Bid Size |
2 |
| Book Value |
0.239 |
| City |
Smyrna |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.28 |
| Current Ratio |
1.539 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
0.2861 |
| Day Low |
0.2751 |
| Debt To Equity |
18.353 |
| Display Name |
GeoVax Labs |
| Dividend Date |
1,600,992,000 |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,774,641,600 |
| Earnings Call Timestamp Start |
1,774,641,600 |
| Earnings Timestamp End |
1,774,296,000 |
| Earnings Timestamp Start |
1,774,296,000 |
| Ebitda |
-20,470,740 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
0.036 |
| Enterprise Value |
-739,943 |
| Eps Forward |
-0.86 |
| Eps Trailing Twelve Months |
-8.84 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
0.5165 |
| Fifty Day Average Change |
-0.2365 |
| Fifty Day Average Change Percent |
-0.45788965 |
| Fifty Two Week Change Percent |
-98.13245 |
| Fifty Two Week High |
15.75 |
| Fifty Two Week High Change |
-15.47 |
| Fifty Two Week High Change Percent |
-0.98222226 |
| Fifty Two Week Low |
0.271 |
| Fifty Two Week Low Change |
0.009000003 |
| Fifty Two Week Low Change Percent |
0.033210345 |
| Fifty Two Week Range |
0.271 - 15.75 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,601,040,600,000 |
| Float Shares |
6,922,667 |
| Forward Eps |
-0.86 |
| Forward P E |
-0.3255814 |
| Free Cashflow |
-10,819,786 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
19 |
| Fullday Change |
-0.0022999942 |
| Fullday Change Percent |
-0.81473404 |
| Fullday Price |
0.28 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Gross Profits |
-15,051,904 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00029999999 |
| Held Percent Institutions |
0.09774 |
| Implied Shares Outstanding |
10,102,871 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,768,176,000 |
| Last Split Factor |
1:25 |
| Long Business Summary |
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia. |
| Long Name |
GeoVax Labs, Inc. |
| Market |
us_market |
| Market Cap |
2,828,804 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_12056751 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-20,425,836 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
12,713,534 |
| Number Of Analyst Opinions |
2 |
| Open |
0.2823 |
| Operating Cashflow |
-18,369,716 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
678 384 7220 |
| Previous Close |
0.2823 |
| Price Hint |
4 |
| Price To Book |
1.1715481 |
| Price To Sales Trailing12 Months |
Infinity |
| Profit Margins |
0.0 |
| Quick Ratio |
1.159 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.0022999942 |
| Regular Market Change Percent |
-0.81473404 |
| Regular Market Day High |
0.2861 |
| Regular Market Day Low |
0.2751 |
| Regular Market Day Range |
0.2751 - 0.2861 |
| Regular Market Open |
0.2823 |
| Regular Market Previous Close |
0.2823 |
| Regular Market Price |
0.28 |
| Regular Market Time |
1,791,909,646 |
| Regular Market Volume |
101,968 |
| Return On Assets |
-2.56799 |
| Return On Equity |
-8.91589 |
| Revenue Per Share |
0.0 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
10,102,871 |
| Shares Percent Shares Out |
0.0279 |
| Shares Short |
281,773 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
367,575 |
| Short Name |
GeoVax Labs, Inc. |
| Short Percent Of Float |
0.0279 |
| Short Ratio |
0.89 |
| Source Interval |
15 |
| State |
GA |
| Symbol |
GOVX |
| Target High Price |
10.0 |
| Target Low Price |
10.0 |
| Target Mean Price |
10.0 |
| Target Median Price |
10.0 |
| Total Cash |
3,143,422 |
| Total Cash Per Share |
0.427 |
| Total Debt |
323,141 |
| Total Revenue |
0 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-8.84 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.5479 |
| Two Hundred Day Average Change |
-1.2679 |
| Two Hundred Day Average Change Percent |
-0.8191098 |
| Type Disp |
Equity |
| Volume |
101,968 |
| Website |
https://www.geovax.com |
| Zip |
30,080 |